scholarly article | Q13442814 |
P50 | author | Michiaki Kubo | Q42316443 |
Richard Weinshilboum | Q52447985 | ||
Mark J Ratain | Q87725760 | ||
P2093 | author name string | Kathleen M Giacomini | |
Taisei Mushiroda | |||
Sook Wah Yee | |||
P2860 | cites work | Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update | Q24567766 |
A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients | Q34215820 | ||
Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing. | Q34345953 | ||
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α-based regimens | Q34375569 | ||
A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia | Q34433052 | ||
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. | Q37107608 | ||
Human leukocyte antigen-associated drug hypersensitivity | Q38058954 | ||
ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. | Q39920642 | ||
Genetic variants associated with phenytoin-related severe cutaneous adverse reactions | Q46788949 | ||
Massive schizophrenia genomics study offers new drug directions | Q87602053 | ||
P433 | issue | 1 | |
P921 | main subject | genome-wide association study | Q1098876 |
P304 | page(s) | 1 | |
P577 | publication date | 2016-11-25 | |
P1433 | published in | Nature Reviews Drug Discovery | Q45998 |
P1476 | title | Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine | |
P478 | volume | 16 |
Q57135523 | A framework for large-scale metabolome drug profiling links coenzyme A metabolism to the toxicity of anti-cancer drug dichloroacetate |
Q93243749 | A scientist engineer's contribution to therapeutic discovery and development |
Q57557226 | Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population |
Q91865303 | Benefits and limitations of genome-wide association studies |
Q47377237 | Biomarkers: Delivering on the expectation of molecularly driven, quantitative health |
Q55208199 | CATCH-KB: Establishing a Pharmacogenomics Variant Repository for Chemotherapy-Induced Cardiotoxicity. |
Q38370270 | Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions |
Q54983009 | Exploring the Potential of Direct-To-Consumer Genomic Test Data for Predicting Adverse Drug Events. |
Q50123812 | Full genetic analysis for genome-wide association study of Fangji: a powerful approach for effectively dissecting the molecular architecture of personalized traditional Chinese medicine. |
Q90916419 | HLA-B*51:01 and CYP2C9*3 Are Risk Factors for Phenytoin-Induced Eruption in the Japanese Population: Analysis of Data From the Biobank Japan Project |
Q52431756 | Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective from the International Transporter Consortium. |
Q58769239 | Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls |
Q92555536 | Personalized Medicine and the Power of Electronic Health Records |
Q91616137 | Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell |
Q90470606 | Screening of Genetic Factor in the Interaction Between Periodontitis and Metabolic Traits Using Candidate Gene Association Study (CGAS) |
Q47355032 | The RA-MAP Consortium: a working model for academia-industry collaboration. |
Q87954788 | The genetics of antipsychotic response in schizophrenia |
Q58786509 | The impact of genome-wide association studies on biomedical research publications |
Q45943634 | The influence of big (clinical) data and genomics on precision medicine and drug development. |
Q50199930 | The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variants |
Q64234744 | Translating Pharmacogenetics and Pharmacogenomics to the Clinic: Progress in Human and Veterinary Medicine |
Q56889079 | Translational -omics: Future potential and current challenges in precision medicine |